These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 14636273

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Myelofibrosis in primary myelodysplastic syndromes: a retrospective study of 352 patients.
    Maschek H, Georgii A, Kaloutsi V, Werner M, Bandecar K, Kressel MG, Choritz H, Freund M, Hufnagl D.
    Eur J Haematol; 1992 Apr; 48(4):208-14. PubMed ID: 1592101
    [Abstract] [Full Text] [Related]

  • 23. [Myelofibrosis in patients with chronic myeloid leukemia treated with interferon-alpha].
    Kumas Sotiris, Semenova EA, Turkina AG, Zakharova AV, Domracheva EV, Khoroshko ND, Frank GA.
    Arkh Patol; 2003 Apr; 65(4):9-12. PubMed ID: 14518186
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Follow-up studies with sequential bone marrow biopsies in chronic myeloid leukaemia and so-called primary (idiopathic) osteo-myelofibrosis. Evolution of histopathological lesions and clinical course in 40 patients.
    Thiele J, Simon KG, Fischer R, Zankovich R.
    Pathol Res Pract; 1988 Aug; 183(4):434-45. PubMed ID: 3186544
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Myelofibrosis in primary myelodysplastic syndromes: clinical and biological significance.
    Marisavljević D, Rolović Z, Cemerikić V, Bosković D, Colović M.
    Med Oncol; 2004 Aug; 21(4):325-31. PubMed ID: 15579916
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. CD34+ progenitor cells in idiopathic (primary) myelofibrosis: a comparative quantification between spleen and bone marrow tissue.
    Thiele J, Kvasnicka HM, Czieslick C.
    Ann Hematol; 2002 Feb; 81(2):86-9. PubMed ID: 11907788
    [Abstract] [Full Text] [Related]

  • 30. Myelofibrosis: response to busulfan after hydroxyurea failure.
    Naqvi T, Baumann MA.
    Int J Clin Pract; 2002 May; 56(4):312-3. PubMed ID: 12074218
    [Abstract] [Full Text] [Related]

  • 31. The reversal of myelofibrosis associated with chronic myelogenous leukemia after allogeneic bone marrow transplantation.
    Oblon DJ, Elfenbein GJ, Braylan RC, Jones J, Weiner RS.
    Exp Hematol; 1983 Aug; 11(7):681-5. PubMed ID: 6350032
    [Abstract] [Full Text] [Related]

  • 32. Bone marrow features improve prognostic efficiency in multivariate risk classification of chronic-phase Ph(1+) chronic myelogenous leukemia: a multicenter trial.
    Kvasnicka HM, Thiele J, Schmitt-Graeff A, Diehl V, Zankovich R, Niederle N, Leder LD, Schaefer HE.
    J Clin Oncol; 2001 Jun 15; 19(12):2994-3009. PubMed ID: 11408494
    [Abstract] [Full Text] [Related]

  • 33. Evolution of fibro-osteosclerotic bone marrow lesions in primary (idiopathic) osteomyelofibrosis--a histomorphometric study on sequential trephine biopsies.
    Thiele J, Chen YS, Kvasnicka HM, Diehl V, Fischer R.
    Leuk Lymphoma; 1994 Jun 15; 14(1-2):163-9. PubMed ID: 7920225
    [Abstract] [Full Text] [Related]

  • 34. Chemotherapy resolves symptoms and reverses marrow fibrosis in myelofibrosis.
    Manoharan A, Pitney WR.
    Scand J Haematol; 1984 Nov 15; 33(5):453-9. PubMed ID: 6515328
    [Abstract] [Full Text] [Related]

  • 35. The role of interferon-alpha in the treatment of idiopathic myelofibrosis.
    Bachleitner-Hofmann T, Gisslinger H.
    Ann Hematol; 1999 Dec 15; 78(12):533-8. PubMed ID: 10647876
    [Abstract] [Full Text] [Related]

  • 36. Evolution of bone marrow fibrosis and stromal antigenic expression in chronic myeloid leukemia on alpha interferon and Ara-C therapy.
    Straetmans N, Ma DD, Nevell DF, Arthur C.
    Hematopathol Mol Hematol; 1996 Dec 15; 10(4):213-22. PubMed ID: 9042664
    [Abstract] [Full Text] [Related]

  • 37. Effects of the tyrosine kinase inhibitor imatinib mesylate (STI571) on bone marrow features in patients with chronic myelogenous leukemia.
    Thiele J, Kvasnicka HM, Schmitt-Graeff A, Kriener S, Engels K, Staib P, Griesshammer M, Waller CF, Ottmann OG, Hansmann ML.
    Histol Histopathol; 2004 Oct 15; 19(4):1277-88. PubMed ID: 15375771
    [Abstract] [Full Text] [Related]

  • 38. Comparative effects of interferon and hydroxyurea on bone marrow fibrosis in chronic myelogenous leukemia.
    Thiele J, Kvasnicka HM.
    Leuk Lymphoma; 2001 Oct 15; 42(5):855-62. PubMed ID: 11697640
    [Abstract] [Full Text] [Related]

  • 39. Dynamics of bone marrow changes in patients with chronic idiopathic myelofibrosis following allogeneic stem cell transplantation.
    Thiele J, Kvasnicka HM, Dietrich H, Stein G, Hann M, Kaminski A, Rathjen N, Metz KA, Beelen DW, Ditschkowski M, Zander A, Kroeger N.
    Histol Histopathol; 2005 Jul 15; 20(3):879-89. PubMed ID: 15944939
    [Abstract] [Full Text] [Related]

  • 40. Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/myeloproliferative diseases.
    Orazi A.
    Pathobiology; 2007 Jul 15; 74(2):97-114. PubMed ID: 17587881
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.